Catalyst Wire Dossier Catalyst Wire Dossier

ropivacaine 0.2%

ropivacaine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ropivacaine 0.2%, covering 2023-05-26 to 2023-05-26. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate Efficacy Levobupivacaine 0.125% Versuss Ropivacaine 0.2% in Hemodynamic Alterations in Labor and Fetal Repercussions [Phase 4]

See pricing